» Articles » PMID: 28013098

Toward Precision Smoking Cessation Treatment I: Moderator Results from a Factorial Experiment

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2016 Dec 26
PMID 28013098
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The development of tobacco use treatments that are effective for all smokers is critical to improving clinical and public health. The Multiphase Optimization Strategy (MOST) uses highly efficient factorial experiments to evaluate multiple intervention components for possible inclusion in an optimized tobacco use treatment. Factorial experiments permit analyses of the influence of patient characteristics on main and interaction effects of multiple, relatively discrete, intervention components. This study examined whether person-factor and smoking characteristics moderated the main or interactive effects of intervention components on 26-week self-reported abstinence rates.

Methods: This fractional factorial experiment evaluated six smoking cessation intervention components among primary care patients (N=637): Prequit Nicotine Patch vs. None, Prequit Nicotine Gum vs. None, Preparation Counseling vs. None, Intensive Cessation In-Person Counseling vs. Minimal, Intensive Cessation Telephone Counseling vs. Minimal, and 16 vs. 8 Weeks of Combination Nicotine Replacement Therapy (NRT; nicotine patch+nicotine gum).

Results: Both psychiatric history and smoking heaviness moderated intervention component effects. In comparison with participants with no self-reported history of a psychiatric disorder, those with a positive history showed better response to 16- vs. 8-weeks of combination NRT, but a poorer response to counseling interventions. Also, in contrast to light smokers, heavier smokers showed a poorer response to counseling interventions.

Conclusions: Heavy smokers and those with psychiatric histories demonstrated a differential response to intervention components. This research illustrates the use of factorial designs to examine the interactions between person characteristics and relatively discrete intervention components. Future research is needed to replicate these findings.

Citing Articles

Differences in the effectiveness of individual-level smoking cessation interventions by socioeconomic status.

Theodoulou A, Fanshawe T, Leavens E, Theodoulou E, Wu A, Heath L Cochrane Database Syst Rev. 2025; 1:CD015120.

PMID: 39868569 PMC: 11770844. DOI: 10.1002/14651858.CD015120.pub2.


Distributive randomization: a pragmatic fractional factorial design to screen or evaluate multiple simultaneous interventions in a clinical trial.

Haviari S, Mentre F BMC Med Res Methodol. 2024; 24(1):64.

PMID: 38468221 PMC: 11340141. DOI: 10.1186/s12874-024-02191-9.


Intervention Optimization: A Paradigm Shift and Its Potential Implications for Clinical Psychology.

Collins L, Nahum-Shani I, Guastaferro K, Strayhorn J, Vanness D, Murphy S Annu Rev Clin Psychol. 2024; 20(1):21-47.

PMID: 38316143 PMC: 11245367. DOI: 10.1146/annurev-clinpsy-080822-051119.


Ending Tobacco Use Through Interactive Tailored Messaging for Cambodian People With HIV (Project EndIT): Protocol for a Randomized Controlled Trial.

Bui T, Hoogland C, Chhea C, Sopheab H, Ouk V, Samreth S JMIR Res Protoc. 2023; 12:e48923.

PMID: 37384390 PMC: 10365624. DOI: 10.2196/48923.


Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.

Theodoulou A, Chepkin S, Ye W, Fanshawe T, Bullen C, Hartmann-Boyce J Cochrane Database Syst Rev. 2023; 6:CD013308.

PMID: 37335995 PMC: 10278922. DOI: 10.1002/14651858.CD013308.pub2.


References
1.
van der Meer R, Willemsen M, Smit F, Cuijpers P . Smoking cessation interventions for smokers with current or past depression. Cochrane Database Syst Rev. 2013; (8):CD006102. DOI: 10.1002/14651858.CD006102.pub2. View

2.
Shaham Y, Shalev U, Lu L, de Wit H, Stewart J . The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl). 2002; 168(1-2):3-20. DOI: 10.1007/s00213-002-1224-x. View

3.
Piper M, Smith S, Schlam T, Fleming M, Bittrich A, Brown J . Psychiatric disorders in smokers seeking treatment for tobacco dependence: relations with tobacco dependence and cessation. J Consult Clin Psychol. 2010; 78(1):13-23. PMC: 2813467. DOI: 10.1037/a0018065. View

4.
Carpenter M, Jardin B, Burris J, Mathew A, Schnoll R, Rigotti N . Clinical strategies to enhance the efficacy of nicotine replacement therapy for smoking cessation: a review of the literature. Drugs. 2013; 73(5):407-26. PMC: 3662024. DOI: 10.1007/s40265-013-0038-y. View

5.
Leventhal A, Ameringer K, Osborn E, Zvolensky M, Langdon K . Anxiety and depressive symptoms and affective patterns of tobacco withdrawal. Drug Alcohol Depend. 2013; 133(2):324-9. PMC: 4049140. DOI: 10.1016/j.drugalcdep.2013.06.015. View